Loading news...
PODD's Omnipod 5 momentum and strong growth outlook highlight upside, but macro pressures and rising competition could challenge its near-term performance.
Insulet (PODD) reported earnings 30 days ago. What's next for the stock?
NEW YORK, March 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Insulet Corporation ("Insulet" or the "Company") (NASDAQ: PODD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON INSULET CORPORATION (PODD), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On March 12, 2026, Insulet d.
Insulet CEO Called Omnipod 5 "Reliable" and a "Favorite Pump" on February 18 -- Two Weeks Later, the Company Disclosed a Voluntary Recall Covering Thousands of Defective Pods NEW YORK, March 18, 2026 /PRNewswire/ -- On February 18, 2026, Insulet Corp. (NASDAQ: PODD) CEO Ashley McEvoy told investors on the Q4 2025 earnings call that "our results in the fourth quarter are a testament to the reliability, consistency and broad appeal of Omnipod." On March 12, 2026, the Company filed an 8-K disclosing a voluntary medical-device correction for Omnipod 5 pods due to an insulin-leakage defect linked to eighteen serious adverse events -- and PODD shares fell 6.9%.
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON INSULET CORPORATION (PODD), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 12, 2026, Insulet disclosed that it had “initiated a vo.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INSULET CORPORATION (PODD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by.
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
New York, New York--(Newsfile Corp. - March 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Insulet Corporation ("Insulet Corporation") (NASDAQ: PODD) concerning potential violations of the federal securities laws. During that same February 18 earnings call, McEvoy stated that "strong clinical evidence and real-world outcomes continue to earn prescriber and patient confidence" and described Omnipod 5 as the "favorite pump" for both type-1 and type-2 users in 2025.
Ausdal Financial Partners Inc. purchased a new position in shares of Insulet Corporation (NASDAQ: PODD) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,680 shares of the medical instruments supplier's stock, valued at approximately $1,136,000. A number of other
Insulet Corporation (NASDAQ: PODD - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Friday. The company traded as low as $220.28 and last traded at $226.71, with a volume of 300006 shares traded. The stock had previously closed at $236.07. Key Headlines Impacting Insulet Here are the key news
-link data-ticker=GOOGL data-exchange=NASDAQ href=https://www.benzinga.com/quote/GOOGL target=_blank rel=noopener>(NASDAQ: GOOGL), One week after we celebrated the International Women's day, here is a stark reminder how the C-suite remains underrepresented by women.Data from a leadership-focused ETF underscores how uncommon female leadership remains among large U.S. companies. The Wedbush ReturnOnLeadership U.S. Large-Cap ETF (ARCA: EXEQ) universe of 50 companies, only about 10% are led by women CEOs. Those include Jayshree Ullal of Arista Networks Inc (NYSE: ANET), Lori Koch of DuPont de Nemours Inc (NYSE: DD), Martina Cheung of S&P Global Inc (NYSE: SPGI), Ashley McEvoy of Insulet Corp (NASDAQ: PODD) and Debra Cafaro of Ventas Inc (NYSE: VTR). The ETF tracks companies ranked through a leadership execution framework developed by Indiggo. Janeen Gelbart, co-founder and CEO of the firm, said the methodology evaluates corporate leadership broadly rather than focusing on individual executives.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON INSULET CORPORATION (PODD), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? O.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INSULET CORPORATION (PODD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by e.
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON INSULET CORPORATION (PODD), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 12, 2026, Insulet disclosed that it had “initiated a vol.
Insulet Corporation (NASDAQ: PODD - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 2,817,783 shares, an increase of 86.4% from the February 12th total of 1,511,612 shares. Based on an average daily volume of 1,172,256 shares, the
Insulet has recalled specific batches of its insulin-delivery pods in the U.S. after finding a manufacturing defect that could stop diabetic users from getting their full dose of the blood sugar-regulating hormone, the medical device maker said on Thursday.
ACTON, Mass.--(BUSINESS WIRE)--Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.
ACTON, Mass.--(BUSINESS WIRE)--Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes.
ACTON, Mass.--(BUSINESS WIRE)--Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at ATTD.